Skye Bioscience, Inc.
SKYE
$2.23
$0.3518.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.06M | 17.11M | 25.74M | 35.31M | 48.59M |
| Total Receivables | 7.40K | 9.50K | 10.50K | 16.80K | 13.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 415.20K | 1.22M | 504.90K | 3.71M | 1.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 472.20K | 225.30K | 841.60K | 883.40K | 719.90K |
| Total Current Assets | 10.96M | 18.57M | 27.09M | 39.92M | 50.58M |
|
|
|||||
| Total Current Assets | 10.96M | 18.57M | 27.09M | 39.92M | 50.58M |
| Net Property, Plant & Equipment | 66.60K | 813.90K | 1.17M | 1.35M | 1.52M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.30K | 35.90K | 53.90K | 53.90K | 53.90K |
| Total Assets | 11.03M | 19.42M | 28.31M | 41.32M | 52.16M |
|
|
|||||
| Total Accounts Payable | 4.28M | 3.94M | 2.03M | 2.83M | 3.22M |
| Total Accrued Expenses | 1.66M | 3.58M | 3.91M | 3.29M | 3.09M |
| Short-term Debt | 143.10K | 250.30K | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.70K | 61.00K | 189.60K | 201.60K | 195.00K |
| Total Finance Division Other Current Liabilities | 5.42M | 2.57M | 2.07M | 2.05M | 1.81M |
| Total Other Current Liabilities | 5.42M | 2.57M | 2.07M | 2.05M | 1.81M |
| Total Current Liabilities | 11.53M | 10.40M | 8.21M | 8.37M | 8.31M |
|
|
|||||
| Total Current Liabilities | 11.53M | 10.40M | 8.21M | 8.37M | 8.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 143.10K | 250.30K | -- | -- | -- |
| Capital Leases | -- | -- | 84.00K | 120.20K | 172.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.53M | 10.40M | 8.29M | 8.49M | 8.48M |
|
|
|||||
| Common Stock & APIC | 209.67M | 208.40M | 206.90M | 205.27M | 203.35M |
| Retained Earnings | -210.17M | -199.38M | -186.87M | -172.43M | -159.68M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -497.30K | 9.01M | 20.02M | 32.84M | 43.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -497.30K | 9.01M | 20.02M | 32.84M | 43.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -497.30K | 9.01M | 20.02M | 32.84M | 43.68M |
|
|
|||||